Importantly, the slight increase of PCA3 did not significantly alter stratification of BPH cases with and without inflammation into risk groups based on the combined evaluation of PCA3, AMACR and % free PSA (p = 0.89). Here, PCA3 is linked to benign prostatic hyperplasia.